Petros Pharmaceuticals, Inc. (PTPI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 725.4K | 1.58M | 1.42M | 1.39M | -364.25K | 1.67M | 1.99M |
| Revenue Growth % | - | -100% | -100% | -100% | -100% | 299.15% | -5.87% | -28.71% | -44.84% | -145.64% | 214.88% | -52.37% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 264.75K | 287K | 329.11K | 1.05M | 158.15K | 408.48K | 513.86K |
| COGS % of Revenue | - | - | - | - | - | 36.5% | 18.21% | 23.15% | 75.58% | -43.42% | 24.39% | 25.77% |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 460.65K | 1.29M | 1.09M | 339.14K | -522.4K | 1.27M | 1.48M |
| Gross Margin % | - | - | - | - | - | 63.5% | 81.79% | 76.85% | 24.42% | 143.42% | 75.61% | 74.23% |
| Gross Profit Growth % | - | -100% | -100% | -100% | -100% | 188.18% | 1.83% | -26.2% | -82.76% | -527.65% | 172.59% | -58.16% |
| Operating Expenses | 1.03M | 391.49K | 990.74K | 1.8M | 1.46M | 9.59M | 3.63M | 3.37M | 4.27M | 4.52M | 6.07M | 3.94M |
| OpEx % of Revenue | - | - | - | - | - | 1322.16% | 230.22% | 237.31% | 307.27% | -1239.87% | 362.63% | 197.74% |
| Selling, General & Admin | 1.03M | 391.49K | 0 | 1.8M | 1.46M | 1.45M | 2.3M | 2.29M | 2.71M | 2.88M | 2M | 2.25M |
| SG&A % of Revenue | - | - | - | - | - | 199.85% | 145.99% | 160.86% | 195.24% | -790.47% | 119.54% | 112.82% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 101.94K | 588.36K | 368.8K | 1.56M | 834.33K | 389.09K | 866.58K |
| R&D % of Revenue | - | - | - | - | - | 14.05% | 37.32% | 25.94% | 112.04% | -229.06% | 23.23% | 43.46% |
| Other Operating Expenses | 0 | 0 | 990.74K | 0 | 0 | 1000K | 739.45K | 717.84K | 0 | 802.58K | 1000K | 826.79K |
| Operating Income | -1.03M | -391.49K | -990.74K | -1.8M | -1.46M | -9.13M | -2.34M | -2.28M | -3.93M | -5.04M | -4.81M | -2.46M |
| Operating Margin % | - | - | - | - | - | -1258.75% | -148.43% | -160.46% | -282.85% | 1383.29% | -287.02% | -123.51% |
| Operating Income Growth % | 29.57% | 95.71% | 57.66% | 21.05% | 62.88% | -81.22% | 51.32% | 7.39% | -200.03% | -22.86% | 64.84% | -48.24% |
| EBITDA | -987.04K | -391.49K | -282.93K | -1.8M | -1.46M | -8.46M | -1.57M | -1.56M | -3.17M | -4.1M | -3.95M | -1.6M |
| EBITDA Margin % | - | - | - | - | - | -1166.76% | -99.69% | -109.96% | -228.6% | 1126.65% | -235.65% | -80.41% |
| EBITDA Growth % | 32.32% | 95.37% | 82% | -15.21% | 54.06% | -106.24% | 60.18% | 2.52% | -604.01% | -28.85% | 67.42% | -1494.71% |
| D&A (Non-Cash Add-back) | 0 | 0 | 707.8K | 0 | 0 | 667.29K | 768.26K | 717.84K | 753.53K | 934.79K | 860.34K | 859.33K |
| EBIT | -987.04K | -391.49K | -922.72K | -1.8M | -1.46M | -9.11M | -2.06M | -547.51K | -2.04M | 443.97K | -4.42M | -2.41M |
| Net Interest Income | 40.14K | 53.28K | 67.01K | 88.85K | 47.79K | -142.72K | -82.91K | 4.88K | 31.61K | 101.77K | 37.13K | -83.88K |
| Interest Income | 40.14K | 53.28K | 67.01K | 88.85K | 47.79K | 24.74K | 75.82K | 119.39K | 151.82K | 227.59K | 168.48K | 52.92K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 167.46K | 158.73K | 114.51K | 120.21K | 125.82K | 131.35K | 136.8K |
| Other Income/Expense | 40.14K | 54.98K | 68.01K | -240.49K | 258.81K | -143K | 119.09K | 1.62M | 1.77M | 5.36M | 257.13K | -83.88K |
| Pretax Income | -987.04K | -336.51K | -922.72K | -2.04M | -1.2M | -9.27M | -2.22M | -662.03K | -2.16M | 318.15K | -4.55M | -2.55M |
| Pretax Margin % | - | - | - | - | - | -1278.38% | -140.87% | -46.57% | -155.72% | -87.34% | -271.67% | -127.72% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -987.04K | -336.51K | -922.72K | 5.43M | -2.26M | -9.27M | -2.22M | -662.03K | -2.16M | 318.15K | -4.55M | -2.55M |
| Net Margin % | - | - | - | - | - | -1278.38% | -140.87% | -46.57% | -155.72% | -87.34% | -271.67% | -127.72% |
| Net Income Growth % | 56.33% | 96.37% | 58.45% | 920.64% | -4.5% | -3014.8% | 51.19% | 74% | -56.15% | 107.54% | 67.1% | -40.56% |
| Net Income (Continuing) | -987.04K | -336.51K | -922.72K | -2.04M | -1.2M | -9.27M | -2.22M | -662.03K | -2.16M | 318.15K | -4.55M | -2.55M |
| Discontinued Operations | 0 | 1000K | 0 | 500.82K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.02 | 8.58 | -0.03 | -1.29 | -9.37 | -0.13 | -0.53 | -0.37 | -1.69 | -2.10 | -2.85 | -1.20 |
| EPS Growth % | 99.77% | 6700% | 94.85% | -248.65% | -454.44% | 93.81% | 81.4% | 69.17% | -156.06% | -3.45% | 57.4% | -36.36% |
| EPS (Basic) | -0.02 | 8.58 | -0.03 | -1.29 | -9.37 | -0.13 | -1.15 | -0.37 | -1.69 | -2.10 | -2.85 | -1.20 |
| Diluted Shares Outstanding | 46.22M | 280.65M | 42.28M | 25.92M | 1.16M | 80.26M | 9.83M | 7.39M | 4.76M | 2.38M | 2.12M | 2.12M |
| Basic Shares Outstanding | 46.22M | 280.65M | 42.28M | 25.92M | 1.16M | 80.26M | 4.16M | 1.79M | 1.28M | 151.49K | 1.6M | 2.12M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |